egtazic acid has been researched along with Electron Transport Chain Deficiencies, Mitochondrial in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Cui, X; Du, T; Jing, X; Li, T; Liu, Q; Liu, X; Wang, G; Wang, Q; Zhang, W | 1 |
1 other study(ies) available for egtazic acid and Electron Transport Chain Deficiencies, Mitochondrial
| Article | Year |
|---|---|
Calcium chelator BAPTA‑AM protects against iron overload‑induced chondrocyte mitochondrial dysfunction and cartilage degeneration.
Topics: Animals; Apoptosis; Calcium Chelating Agents; Cartilage Diseases; Cartilage, Articular; Cell Survival; Cells, Cultured; Chondrocytes; Egtazic Acid; Ferric Compounds; Iron Overload; Male; Mice; Mice, Inbred C57BL; Mitochondria; Mitochondrial Diseases; Osteoarthritis; Protective Agents; Quaternary Ammonium Compounds; Reactive Oxygen Species | 2021 |